Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegfilgrastim for Stem Cell Mobilization in Children
NCT00751894Phase 2Unknown
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pegfilgrastim in solid tumor, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Percentage of children achieving at least 5x10e6 CD34 cells with a standard apheresis. Status: unknown.
02
Drugs
pegfilgrastim
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT00751894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00751894.